Schizophrenia Trial, Recruiting NCT07056894 Sponsor: Nova Scotia Health Authority Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07056894
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 16 and 30 years of age who are already enrolled in an Early Intervention Services for Psychosis program in Nova Scotia, or the Psychosis Intervention Early Recovery program in Newfoundland.
  • People who have been diagnosed with a primary psychotic disorder, such as schizophrenia, schizoaffective disorder, or an unspecified schizophrenia spectrum disorder.
  • People who have been living with a psychotic illness for less than 5 years.
  • People who have problematic alcohol or cannabis use, as measured by a score of 8 or higher on a standard screening tool used by healthcare professionals (confirm with trial site).

Who may not be able to join:

  • People who currently have a stimulant use disorder (a serious pattern of problematic use of stimulant drugs such as cocaine or methamphetamine).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philip G Tibbo, MD, Nova Scotia Health Authority

Phone: 902-473-7474

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nova Scotia Health Authority
Registry
ClinicalTrials.gov
Start date
27 March 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in cannabis consumption; Change in problematic cannabis use; Change in alcohol consumption; Change in problematic alcohol use

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov